Literature DB >> 26293778

A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications.

Tania L Slatter1, Natalie Gly Hung2, William M Clow3, Janice A Royds1, Celia J Devenish3, Noelyn A Hung1.   

Abstract

Viral infections are known to adversely affect pregnancy, but scant attention has been given to human papilloma virus (HPV) infection. We aimed to determine the molecular and histopathological features of placental HPV infection, in association with pregnancy complications including fetal growth restriction, pre-maturity, pre-eclampsia, and diabetes. Three hundred and thirty-nine placentae were selected based on the presence or absence of pregnancy complications. Five independent methods were used to identify HPV in the placenta, namely, immunohistochemistry for L1 viral capsid, in situ hybridization to high-risk HPV DNA, PCR, western blotting, and transmission electron microscopy. Pregnancy complications and uterine cervical smear screening results were correlated with placental HPV histopathology. In this study, which was deliberately biased towards complications, HPV was found in the decidua of 75% of placentae (253/339) and was statistically associated with histological acute chorioamnionitis (P<0.05). In 14% (35/253) of the HPV positive cases, HPV L1 immunoreactivity also occurred in the villous trophoblast where it was associated with a lymphohistiocytic villitis (HPV-LHV), and was exclusively of high-risk HPV type. HPV-LHV significantly associated with fetal growth restriction, preterm delivery, and pre-eclampsia (all P<0.05). All cases of pre-eclampsia (20/20) in our cohort had high-risk placental HPV. A further 55 cases (22%, 55/253) of HPV positive placentae had minimal villous trophoblast HPV L1 immunoreactivity, but a sclerosing pauci-immune villitis, statistically associated with diabetes (49.1%, 27/55, P<0.05). For women with placental HPV, 33% (69/207) had an HPV-related positive smear result before pregnancy compared with (9.4% 8/85) of women with HPV-negative placentae (P=0.0001). Our findings support further investigations to determine if vaccination of women and men will improve pregnancy outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 26293778     DOI: 10.1038/modpathol.2015.88

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  52 in total

1.  Placental pathologic features of preterm preeclampsia.

Authors:  C M Salafia; J C Pezzullo; J A López-Zeno; S Simmens; V K Minior; A M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

2.  Detection of human papillomavirus deoxyribonucleic acid sequences in amniotic fluid during different periods of pregnancy.

Authors:  E Armbruster-Moraes; L M Ioshimoto; E Leao; M Zugaib
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

3.  Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA.

Authors:  O Malhomme; N Dutheil; M Rabreau; E Armbruster-Moraes; J R Schlehofer; T Dupressoir
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

4.  Human papillomavirus type 18 DNA in gestational trophoblastic tissues and choriocarcinomas.

Authors:  C C Pao; J J Hor; C J Wu; Y F Shi; X Xie; S M Lu
Journal:  Int J Cancer       Date:  1995-11-15       Impact factor: 7.396

5.  Multiple human papillomavirus types replicate in 3A trophoblasts.

Authors:  H You; Y Liu; N Agrawal; C K Prasad; J L Edwards; A F Osborne; S Korourian; C L Lowery; P L Hermonat
Journal:  Placenta       Date:  2007-10-01       Impact factor: 3.481

6.  Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

7.  Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery.

Authors:  Hyun Park; Si Won Lee; In Ho Lee; Hyun Mee Ryu; A Reum Cho; Young Soon Kang; Sung Ran Hong; Sung Soon Kim; Seok Ju Seong; Son Moon Shin; Tae Jin Kim
Journal:  Virol J       Date:  2012-04-12       Impact factor: 4.099

8.  Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.

Authors:  Giuseppe Pannone; Vito Rodolico; Angela Santoro; Lorenzo Lo Muzio; Renato Franco; Gerardo Botti; Gabriella Aquino; Maria Carmela Pedicillo; Simona Cagiano; Giuseppina Campisi; Corrado Rubini; Silvana Papagerakis; Gaetano De Rosa; Maria Lina Tornesello; Franco M Buonaguro; Stefania Staibano; Pantaleo Bufo
Journal:  Infect Agent Cancer       Date:  2012-02-29       Impact factor: 2.965

9.  Viruses and disease: emerging concepts for prevention, diagnosis and treatment.

Authors:  C S Herrington; P J Coates; W P Duprex
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 10.  Monocytes and macrophages in pregnancy and pre-eclampsia.

Authors:  Marijke M Faas; Floor Spaans; Paul De Vos
Journal:  Front Immunol       Date:  2014-06-30       Impact factor: 7.561

View more
  13 in total

Review 1.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

2.  Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis.

Authors:  Joseph Niyibizi; Nadège Zanré; Marie-Hélène Mayrand; Helen Trottier
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

Review 3.  Viral Infections in Pregnancy: A Focus on Ebola Virus.

Authors:  Nicole S Olgun
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

4.  Chronic villitis of unknown etiology: Investigations into viral pathogenesis.

Authors:  Linda M Ernst; Crystal Bockoven; Alexa Freedman; Vivien Wang; Matthew Pellerite; Todd N Wylie; Kristine M Wylie
Journal:  Placenta       Date:  2021-03-01       Impact factor: 3.481

Review 5.  Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.

Authors:  C E Depuydt; J Beert; E Bosmans; G Salembier
Journal:  Facts Views Vis Obgyn       Date:  2016-12

6.  HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa.

Authors:  Heidi Tuominen; Samuli Rautava; Stina Syrjänen; Maria Carmen Collado; Jaana Rautava
Journal:  Sci Rep       Date:  2018-06-28       Impact factor: 4.379

7.  HPV infection and pre-term birth: a data-linkage study using Scottish Health Data.

Authors:  Marian C Aldhous; Ramya Bhatia; Roz Pollock; Dionysis Vragkos; Kate Cuschieri; Heather A Cubie; Jane E Norman; Sarah J Stock
Journal:  Wellcome Open Res       Date:  2019-03-08

Review 8.  Why Human Papillomavirus Acute Infections Matter.

Authors:  Samuel Alizon; Carmen Lía Murall; Ignacio G Bravo
Journal:  Viruses       Date:  2017-10-10       Impact factor: 5.048

9.  HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells.

Authors:  Lea M M Ambühl; Annemarie B Villadsen; Ulrik Baandrup; Karen Dybkær; Suzette Sørensen
Journal:  Pathogens       Date:  2017-09-03

10.  The association between adverse pregnancy outcomes and maternal human papillomavirus infection: a systematic review protocol.

Authors:  Joseph Niyibizi; Nadège Zanré; Marie-Hélène Mayrand; Helen Trottier
Journal:  Syst Rev       Date:  2017-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.